Mohammad Chehelgerdi
About
In The Last Decade
Mohammad Chehelgerdi
30 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Molecular Biology 587
- Biomaterials 478
- Biomedical Engineering 405
- Rehabilitation 297
- Oncology 179
Countries citing papers authored by Mohammad Chehelgerdi
This map shows the geographic impact of Mohammad Chehelgerdi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Chehelgerdi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Chehelgerdi more than expected).
Fields of papers citing papers by Mohammad Chehelgerdi
This network shows the impact of papers produced by Mohammad Chehelgerdi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Chehelgerdi. The network helps show where Mohammad Chehelgerdi may publish in the future.
Co-authorship network of co-authors of Mohammad Chehelgerdi
This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad Chehelgerdi. A scholar is included among the top collaborators of Mohammad Chehelgerdi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad Chehelgerdi. Mohammad Chehelgerdi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 19 | |
| 3 | 5 | |
| 4 | Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy breakdown → | 113 |
| 5 | Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation breakdown → | 552 |
| 6 | 94 | |
| 7 | 96 | |
| 8 | 4 | |
| 9 | 31 | |
| 10 | 5 | |
| 11 | 36 | |
| 12 | 35 | |
| 13 | Molecular characterization, serotypes and phenotypic and genotypic evaluation of antibiotic resistance of the Klebsiella pneumoniae strains isolated from different types of hospital-acquired infections | 4 |
| 14 | 43 | |
| 15 | Skin tissue engineering: wound healing based on stem-cell-based therapeutic strategies breakdown → | 398 |
| 16 | 24 | |
| 17 | Genotyping and antibiotic resistance properties of Helicobacter pylori strains isolated from human and animal gastric biopsies | 3 |
| 18 | 22 | |
| 19 | 2 | |
| 20 | 23 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.